Clinical Trials: Turner Syndrome

Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Aurora : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Hartford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Chicago : University of Chicago

Initiating Transdermal Estradiol Therapy in Turner's Syndrome

Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Kansas City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Chapel Hill : University of North Carolina at Chapel Hill

Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome

Chapel Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Buenos Aires : Hospital de Pediatria Garrahan

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Cordoba : Hospital de Niños de la Santisima Trinidad

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Calgary : University of Calgary - Alberta Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Montréal : CHU Sainte Justine Montréal

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke - Fleurimont

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Vancouver : British Columbia Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Brno : Fakultní nemocnice Brno

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Hradec Kralove : University Hospital Hradec Kralove

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Olomouc : Faculty Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Praha : University Hospital Praha Motol

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Bordeaux : Centre d'Endocrinologie Pédiatrique

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Bordeaux : CHU Bordeaux - Hopital pédiatrique Pellegrin

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Bron : Hôpital Femme-Mère-Enfant

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Cologne : University of Cologne Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

München : University Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Cagliari : Ospedale Microcitemico di Cagliari

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Catania : Centro di Endocrinologia e Diabetologia Pediatrica

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Genova : Istituto Giannina Gaslini - Clinica Pediatrica

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Madrid : Hospital Universitario Gregorio Maran

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Madrid : Hospital Infantil Universitario Niño Jesús

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Madrid : Hospital 12 de Octubre

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Santiago de Compostela : Hospital Clínico Universitario de Santiago de Compostela

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Zaragoza : Hospital Miguel Servet

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Göteborg : Queen Silvia Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Linköping : Faculty of Health Sciences, Linkping University

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Stockholm : Karolinska University Hospital Campus Solna

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Birmingham : Birmingham Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Manchester : Royal Manchester Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study

Sheffield : Sheffield Children's Hospital

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children : the PREDICT Pharmacogenetics Validation Study